¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö : 2019-01-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö : 2019-01-19
±³À°ÀÏÀÚ : 2019-01-19
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B1 ´ë°­´ç  
±³À°ÁÖÁ¦ : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574  
À̸ÞÀÏ : app@app2010.com      
±³À°Á¾·ù : ºñ´¢±â°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í »çÀüµî·Ï 2¸¸¿ø, ÇöÀåµî·Ï 3¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 01-19  08:30~08:50 Registration  () 
±âŸ 01-19  08:50~09:00 Opening remark , Ãà»ç  () 
±³À°½Ã°£ 01-19  09:00~09:20 Critical roles of hMAGEA2 in prostate cancer and development of cancer animal model  ¹Ú¼Û(DGIST) 
±³À°½Ã°£ 01-19  09:20~09:40 Identification of novel biomarkers for diagnosis of metastatic prostate cancer  ÀÌ»ó±Ô(°æºÏ´ë ¾à´ë) 
±³À°½Ã°£ 01-19  09:40~10:00 Expression of AR-V7 in urine derived exosomal RNA and development of CRPC  ±¸ÀÚÀ±(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 01-19  10:00~10:20 Feasibility of ctDNA analysis in prostate cancer  Á¶¿µ³²(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-19  10:20~10:40 ctDNA to predict prognosis of prostate cancer  Á¶ÀºÇØ(³ì½ÊÀÚÁö³ð) 
È޽Ġ01-19  10:40~11:00 Coffee break  () 
±³À°½Ã°£ 01-19  11:00~11:20 Medical travel among non-Seoul residents to seek prostate cancer treatment in medical facilities of Seoul  ±èÀçÇå(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 01-19  11:20~11:40 National practice patterns and medical costs for prostate cancer in Korea across a 10 year periods  °­È£¿ø(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 01-19  11:40~12:00 Lifestyle risk prediction model for prostate cancer in a Korean population  ±è¼ºÇÑ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-19  12:00~12:20 Surgical simulation in Urology  °í¿µÈÖ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 01-19  12:20~12:40 Digital health and future technology  À̰Ǹí(ÃæºÏ´ëÇб³) 
±âŸ 01-19  12:40~12:40 Closing remark  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »õº´µ¿ °Ç¸³±â³ä ºÎõ¼º¸ðº´¿ø ¾È¼¾ÅÍ ½ÉÆ÷Áö¾ö(ºÎõ½Ã ¾È°úÀÇ»çȸ) : 2019-01-21
´ÙÀ½±Û ´ëÇÑ¿Ü°úÇÐȸ ÃÖ¼Òħ½ÀÀû À¯¹æ»ý°Ë ½ÉÆ÷Áö¾ö : 2019-01-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20979 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 11 2024-06-14
20978 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 9 2024-06-14
20977 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 6 2024-06-14
20976 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 9 2024-06-14
20975 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 7 2024-06-14
20974 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 16 2024-06-14
20973 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 5 2024-06-14
20972 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 5 2024-06-14
20971 °­¿ø 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Á¦21Â÷ ¿öÅ©¼ó : 2024-06-21 0 11 2024-06-14
20970 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-21 0 8 2024-06-14
20969 ¼­¿ï ´ëÇѼҾƳ»ºÐºñÇÐȸ 2024³â Á¦1Â÷ Á¤±âÁý´ãȸ(°íÇÁ·Î¶ôƾÇ÷Áõ) : 2024-06-21 0 4 2024-06-14
20968 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 2Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 3 2024-06-14
20967 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(1ÀÏÂ÷) : 2024-06-21 0 2 2024-06-14
20966 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-21 0 1 2024-06-14
20965 Á¦ÁÖ Á¦ÁÖÇѶ󺴿ø º¹°­°æ ½ÉÆ÷Áö¿ò : 2024-06-21 0 2 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷